| 2016 |
ETAA1 accumulates at DNA damage sites via dual RPA-binding motifs and contains a conserved ATR-activation domain (AAD) that directly and potently stimulates ATR kinase activity independently of TopBP1. Simultaneous loss of ETAA1 and TopBP1 causes synthetic lethality with massive genome instability and abrogation of ATR-dependent signalling, establishing ETAA1 as an independent, parallel ATR activator. |
Co-immunoprecipitation, in vitro kinase assays, loss-of-function (siRNA/genetic depletion), immunofluorescence, synthetic lethality analysis |
Nature cell biology |
High |
27723717
|
| 2016 |
ETAA1 contains two RPA-interaction motifs that localize it to stalled replication forks, and a motif with sequence similarity to the TOPBP1 ATR-activation domain that directly binds ATR/ATRIP and activates ATR. ETAA1 also interacts with the BLM/TOP3α/RMI1/RMI2 complex and the ATR/ATRIP complex. ETAA1 functions in parallel to the TOPBP1/RAD9/HUS1/RAD1 pathway. |
Proteomic screens, co-immunoprecipitation, pulldown, in vitro ATR kinase assay, RPA-interaction domain mapping, ETAA1-deficient cell lines with genome instability readouts |
Nature cell biology |
High |
27723720
|
| 2016 |
ETAA1 interacts with RPA via two conserved RPA-binding domains and is recruited to stalled replication forks, where it activates ATR through a conserved N-terminal ATR-activating domain (AAD). Both RPA binding and ATR activation are required for ETAA1 function at stalled forks. |
Co-immunoprecipitation, immunofluorescence, domain-deletion/mutation analysis, ATR signalling assays in ETAA1-depleted cells |
Current biology : CB |
High |
27818175
|
| 2019 |
Both ETAA1 and TOPBP1 AADs contain a predicted coiled-coil motif required for ATR activation in vitro and in cells. Mutation of the coiled-coil does not alter AAD oligomerization but impairs binding of the AADs to ATR, indicating that the coiled-coil mediates ATR binding as a shared activation mechanism. |
Bioinformatic analysis, in vitro kinase assays, co-immunoprecipitation, immunofluorescence-based signalling assays, mutagenesis |
The Journal of biological chemistry |
High |
30940728
|
| 2019 |
RPA-coated single-stranded DNA (ssDNA) greatly stimulates ETAA1-mediated activation of ATR-ATRIP. In a defined in vitro reconstitution system, full-length recombinant ETAA1 activates ATR-ATRIP, and this activity is strongly enhanced when ETAA1 is bound to RPA on ssDNA, establishing RPA-ssDNA as a direct positive effector of ETAA1-mediated ATR activation. |
In vitro reconstitution with recombinant proteins, Xenopus egg-extract system, ATR-ATRIP kinase assay with defined components |
Cell cycle (Georgetown, Tex.) |
High |
30975033
|
| 2019 |
Quantitative phosphoproteomics revealed that ETAA1 predominantly regulates mitotic ATR signalling, while TOPBP1 is the primary ATR activator for replication stress. Inactivation of ATR or ETAA1 (but not TOPBP1) decreases Aurora B kinase activity during mitosis. ETAA1-mediated ATR activation is required for proper chromosome alignment in metaphase and a fully functional spindle assembly checkpoint. |
Quantitative mass spectrometry phosphoproteomics, ETAA1/TOPBP1 knockout/knockdown cells, Aurora B activity assay, live-cell imaging of chromosome alignment, spindle assembly checkpoint assay |
The Journal of cell biology |
High |
30755469
|
| 2019 |
The ATR-activating potential of ETAA1 is controlled by cell cycle- and replication stress-dependent phosphorylation of conserved residues within its AAD. These stimulatory phosphorylations are required for ETAA1 to prevent mitotic chromosome abnormalities following replicative stress. A CRISPR-Cas9 genome-scale screen confirmed ETAA1's ATR-stimulating function becomes indispensable when DNA replication fidelity is compromised. |
CRISPR-Cas9 genome-scale screen, phosphorylation-site mutagenesis, cell cycle and replication stress-dependent phosphorylation analysis, chromosome stability assays |
The Journal of cell biology |
High |
31615875
|
| 2017 |
In mice, ETAA1 deficiency (via exon-2-skipping or truncating alleles) selectively impairs clonal expansion of effector CD8+ and CD4+ T cells following infection/immunization without affecting immune cell development. The defect is cell-autonomous and is associated with increased TP53-induced mRNAs and phosphorylation of H2AX (markers of ATR/ATM-mediated replication stress), linking ETAA1's ATR-activating function (encoded in part by exon 2) to T cell proliferation. |
Forward genetic screen in mice, homozygous mutant breeding, in vivo viral infection/immunization models, cell-autonomous transfer assays, H2AX phosphorylation and p53-target gene expression readouts |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
28607084
|
| 2023 |
p130RB2 binds ETAA1 (but not TopBP1) and is required for the RPA32-ETAA1 interaction under hydroxyurea-induced replication stress. Depletion of p130RB2 reduces ATR activation (phosphorylation of RPA32, Chk1, and ATR itself) and impairs proper S-phase re-progression, establishing p130RB2 as a positive regulator of the RPA32-ETAA1-ATR axis. |
Co-immunoprecipitation, siRNA knockdown, ATR substrate phosphorylation assays, cell cycle analysis, anaphase bridge quantification, rescue experiments |
Biochimica et biophysica acta. Molecular cell research |
Medium |
37201767
|
| 2005 |
ETAA1 (ETAA16) encodes a 926-amino-acid protein (predicted MW ~103 kDa) whose epitope recognized by antibody Ak16 maps to its central region, which is part of an extracellular domain. Cell surface expression detected by flow cytometry is restricted to Ewing's tumour cell lines. The gene locus was mapped to chromosome 2p13-15 by FISH. |
cDNA library immunoscreening, flow cytometry, immunohistochemistry, RT-PCR, FISH |
Cancer immunology, immunotherapy : CII |
Low |
16003559
|